UA12648A - Спосіб одержаhhя твердої лікарської форми - Google Patents

Спосіб одержаhhя твердої лікарської форми

Info

Publication number
UA12648A
UA12648A UA4355988A UA4355988A UA12648A UA 12648 A UA12648 A UA 12648A UA 4355988 A UA4355988 A UA 4355988A UA 4355988 A UA4355988 A UA 4355988A UA 12648 A UA12648 A UA 12648A
Authority
UA
Ukraine
Prior art keywords
solid pharmaceutical
pharmaceutical form
obtaining solid
relates
obtaining
Prior art date
Application number
UA4355988A
Other languages
English (en)
Russian (ru)
Inventor
Ремер Аксель
Зайдель Юрген
Original Assignee
А. Hаттерманн Унд Ко. Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by А. Hаттерманн Унд Ко. Гмбх filed Critical А. Hаттерманн Унд Ко. Гмбх
Publication of UA12648A publication Critical patent/UA12648A/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12Selenazoles; Hydrogenated selenazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
UA4355988A 1987-06-20 1988-06-17 Спосіб одержаhhя твердої лікарської форми UA12648A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (1)

Publication Number Publication Date
UA12648A true UA12648A (uk) 1997-02-28

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4355988A UA12648A (uk) 1987-06-20 1988-06-17 Спосіб одержаhhя твердої лікарської форми

Country Status (25)

Country Link
US (1) US5021242A (uk)
EP (1) EP0296389B1 (uk)
JP (1) JPH0713016B2 (uk)
KR (1) KR970005322B1 (uk)
AT (1) ATE69165T1 (uk)
AU (1) AU603454B2 (uk)
CA (1) CA1310906C (uk)
DD (1) DD271056A5 (uk)
DE (2) DE3720493A1 (uk)
DK (1) DK173628B1 (uk)
ES (1) ES2041736T3 (uk)
FI (1) FI88256C (uk)
GE (1) GEP19960342B (uk)
GR (1) GR3003084T3 (uk)
HU (1) HU200096B (uk)
IE (1) IE63512B1 (uk)
LT (1) LT3669B (uk)
LV (1) LV10381B (uk)
MX (1) MX169170B (uk)
NO (1) NO175133C (uk)
NZ (1) NZ225066A (uk)
PT (1) PT87767B (uk)
RU (1) RU1834657C (uk)
UA (1) UA12648A (uk)
ZA (1) ZA884025B (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
ES2145065T3 (es) * 1993-10-27 2000-07-01 Daiichi Seiyaku Co Preparacion granular.
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US7671211B1 (en) 1999-03-31 2010-03-02 Arne Holmgren Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
CA2511992A1 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008148064A1 (en) * 2007-05-23 2008-12-04 Sunesis Pharmaceuticals, Inc. Weight loss treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
EP4536191A1 (en) * 2022-06-06 2025-04-16 Sound Pharmaceuticals Incorporated Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
NZ225066A (en) 1990-07-26
ES2041736T3 (es) 1996-07-16
LT3669B (en) 1996-01-25
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
AU1811688A (en) 1988-12-22
DK333388A (da) 1988-12-21
DK173628B1 (da) 2001-05-07
HUT50037A (en) 1989-12-28
LV10381A (lv) 1995-02-20
NO175133B (no) 1994-05-30
FI88256B (fi) 1993-01-15
ZA884025B (en) 1988-12-20
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
KR970005322B1 (ko) 1997-04-15
MX169170B (es) 1993-06-23
IE63512B1 (en) 1995-05-03
US5021242A (en) 1991-06-04
LV10381B (en) 1995-06-20
DD271056A5 (de) 1989-08-23
NO882615L (no) 1988-12-21
NO175133C (no) 1994-09-07
PT87767B (pt) 1992-10-30
JPH01100125A (ja) 1989-04-18
AU603454B2 (en) 1990-11-15
GEP19960342B (en) 1996-02-20
JPH0713016B2 (ja) 1995-02-15
DK333388D0 (da) 1988-06-17
RU1834657C (ru) 1993-08-15
GR3003084T3 (en) 1993-02-17
CA1310906C (en) 1992-12-01
IE881628L (en) 1988-12-20
NO882615D0 (no) 1988-06-14
FI882912L (fi) 1988-12-21
FI882912A0 (fi) 1988-06-17
PT87767A (pt) 1989-05-31
ATE69165T1 (de) 1991-11-15
LTIP903A (en) 1995-03-27
KR890000084A (ko) 1989-03-11
DE3866033D1 (de) 1991-12-12
FI88256C (fi) 1993-04-26

Similar Documents

Publication Publication Date Title
UA13038A1 (uk) Спосіб одержаhhя таблеток
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
UA26211A (uk) Спосіб одержаhhя твердої лікарської форми метопролола з регульоваhим його вивільhеhhям
NL930094I2 (nl) Nieuwe antihistaminen, werkwijze voor de bereidingdaarvan en farmaceutische composities, die deze v erbindingen bevatten.
EP0130690A3 (en) Pharmaceutical preparation for remedy of periodontal disease and process for production thereof
NL182535B (nl) Werkwijze ter bereiding van een therapeutisch preparaat, aldus verkregen therapeutisch voorwerp, en werkwijze ter bereiding van een daarvoor geschikt 11-oxo-11-h-pyrido (2,1-b)-chinazolinecarbonzuur of een zout daarvan.
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
BG44538A3 (bg) Метод за получаване на соли на 5-метокси-2-голяма скоба(4 метокси- 3,5-диметил-2-пиридинил)-метил сулфонил голяма скоба-1н-бензимидазол
IL83363A0 (en) Pharmaceutical compositions containing serotonin antagonists and their preparation,and certain novel serotonin antagonists and their production
ES8700935A1 (es) Metodo para producir una forma de dosificacion farmaceutica de liberacion prolongada
AR242187A1 (es) Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
PL273790A1 (en) Method of manufacturing means for administering and/or dosing active substances of medicaments
HUT54657A (en) Process for producing amino acid antagonists with vitalizing effect and pharmaceutical compositions comprising such compounds
IL80853A (en) Process for the production of podophyllotoxin and related compounds,certain intermediates therefor and their preparation
ES428377A1 (es) Procedimiento para la preparacion de tetrahidroacridonas.
EP0235363A3 (en) Sustained release tablets of theophylline
GR3002266T3 (en) Process for the preparation of single dosage administration forms, and administration forms thus obtained
EP0106576A3 (en) Novel 5-membered cyclic compounds, process for production thereof, and pharmaceutical use thereof
DE69431151D1 (de) Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder einen vorlaeufer davon enthalten
NO881152D0 (no) Farmasoeytisk blanding.
ES530359A0 (es) Procedimiento para la produccion de preparados analgesicos abase de paracetamol.
ATE130192T1 (de) Verwendung von 15-deoxyspergualin als arzneimittel.
AU5505990A (en) Polysaccharide mixture with immune stimulating and antiproliferating effect, method of production and medicines containing the substances
HU890492D0 (en) Process for the production of pharmaceutical preparations for curing dyslipaemia
IT8521895V0 (it) Confezione combinata per laproduzione di masse dentarie.